Tech Company M&A Transactions
Alnara Pharmaceuticals Acquisition
On 7/2/2010, Alnara Pharmaceuticals was acquired by Eli Lilly & Co. No transaction price was released.
Transaction Overview
Company Name
Acquired By
Announced On
7/2/2010
Transaction Type
M&A
Amount
Unknown
M&A Terms
Financial terms of the transaction were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
840 Memorial Dr.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Alnara Pharmaceuticals Inc is a pharmaceutical company developing innovative non-systemic protein therapeutics for the treatment of metabolic and inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alexey Margolin
Chief Medical Officer
Lee Brettman
Vice President
Thomas Rowland
Vice President
Hugh Wight
Browse more venture capital transactions:
Prev: 7/2/2010: Invuity venture capital transaction
Next: 7/2/2010: mFormation Technologies venture capital transaction
Share this article
About Our VC Transactions Data
We report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs